drugset / Trial / NCT02099461
Effect of Denosumab on Cellular Biomarkers in the Human Breast
RandomizedParallel-groupOpen-labelBasic science
Summary
To evaluate whether administration of denosumab results in a decrease compared to the control group in proliferation of mammary epithelial cells as measured by the Ki-67 proliferation index.
Timeline
- Start
- 2014-04
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Denosumab | Monoclonal antibody | 60 mg | Subcutaneous |
| Subject | Denosumab | Monoclonal antibody | 120 mg | Subcutaneous |
Indications
No indication recorded.